TAMs show different phenotypes in cancer development, where they have a pro-inflammatory phenotype, generate an anti-tumor type-1 inflammatory response, and suppress tumor cell proliferation by generating TNF, reactive oxygen species (ROS), or phagocytosis during the primary stage of tumor development. The gene discussed is TNF; the disease is cancer.